Emergent Biosolutions Inc (EBS)

Emergent Biosolutions Inc (EBS) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $354M; returns 1 day +0.0%, 1 week -2.4%, 1 year -35.5%.

Emergent BioSolutions Inc. (EBS) is a biopharmaceutical company specializing in the development, manufacturing, and commercialization of vaccines, therapeutics, and medical countermeasures primarily for infectious diseases and biodefense.

Groups EBS belongs to

• Biotechnology
• Buying Back Stock
• Public Safety and Security
• Healthcare
• Biopharmaceutical
• Defense
• Infectious Diseases
• National Security
• Government Contractor
• Public Sector
• Medical Devices
• Pharmaceuticals

EBS financial model: income statement, cash flow and balance sheet